Pediatric Oncology

Top Story

Precision medicine ‘can now be a reality’ for hard-to-treat pediatric cancers

May 20, 2019
Meeting NewsPerspective

Pediatric tumor-sequencing trial finds higher rate of targetable alterations than expected

May 17, 2019
Genetic sequencing of tumors among children with refractory cancer led to about a quarter of those tested being matched with therapies targeting their specific genetic…
Meeting NewsPerspective

Entrectinib induces ‘rapid and durable’ responses in pediatric tumors with gene fusions

May 16, 2019
Children with central nervous system or other solid tumors with specific gene fusions responded to treatment with the investigational tyrosine kinase inhibitor…
FDA News

FDA approves Fragmin, first anticoagulant for children

May 16, 2019
The FDA today approved dalteparin sodium injection to reduce the recurrence of symptomatic venous thromboembolism among children aged at least 1 month. Children with VTE…
More Headlines »

Sickle Cell Disease Forum: Innovation in Drug Development and Emerging Science

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »
Meeting News

VIDEO: Late health problems becoming less common in childhood cancer survivors

June 4, 2017
More »

Ace the Case: A 9-Year-Old Girl With Bruising, Fatigue, Left Hip Pain, and Intermittent Fever for 2 Weeks

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the diagnosis and management of childhood leukemia.
More »